BRAINSTORM CELL THERAPEUTICS INC. Net Cash Provided by (Used in) Financing Activities, Continuing Operations
BRAINSTORM CELL THERAPEUTICS INC. (BCLI) reported Net Cash Provided by (Used in) Financing Activities, Continuing Operations of $75.00 thousand for the 3-month period ending 2017-09-30, per its 10-Q filed 2017-10-17.
Discontinued › Cash Flow › Financing Activities
us-gaap:NetCashProvidedByUsedInFinancingActivitiesContinuingOperations · last filed 2017-10-17
- BRAINSTORM CELL THERAPEUTICS INC. net cash provided by (used in) financing activities, continuing operations for the quarter ending 2017-09-30 was $75.00K.
- BRAINSTORM CELL THERAPEUTICS INC. net cash provided by (used in) financing activities, continuing operations for the quarter ending 2017-06-30 was $30.00K.
- BRAINSTORM CELL THERAPEUTICS INC. net cash provided by (used in) financing activities, continuing operations for the quarter ending 2017-03-31 was $0.00.
- BRAINSTORM CELL THERAPEUTICS INC. net cash provided by (used in) financing activities, continuing operations for the quarter ending 2016-12-31 was $0.00, a 100.00% decline year-over-year.
- BRAINSTORM CELL THERAPEUTICS INC. net cash provided by (used in) financing activities, continuing operations for fiscal 2016 was $0.00, a 100.00% decline from fiscal 2015.
- BRAINSTORM CELL THERAPEUTICS INC. net cash provided by (used in) financing activities, continuing operations for fiscal 2015 was $14.87M, a 53.52% increase from fiscal 2014.
- BRAINSTORM CELL THERAPEUTICS INC. net cash provided by (used in) financing activities, continuing operations for fiscal 2014 was $9.69M, a 170.23% increase from fiscal 2013.
- BRAINSTORM CELL THERAPEUTICS INC. net cash provided by (used in) financing activities, continuing operations for fiscal 2013 was $3.58M, a 30.66% decline from fiscal 2012.
| Period end | Net Cash Provided by (Used in) Financing Activities, Continuing Operations 3 month | Net Cash Provided by (Used in) Financing Activities, Continuing Operations 6 month | Net Cash Provided by (Used in) Financing Activities, Continuing Operations 9 month | Net Cash Provided by (Used in) Financing Activities, Continuing Operations 12 month | Net Cash Provided by (Used in) Financing Activities, Continuing Operations 129 month | Net Cash Provided by (Used in) Financing Activities, Continuing Operations 132 month | Net Cash Provided by (Used in) Financing Activities, Continuing Operations 135 month | Net Cash Provided by (Used in) Financing Activities, Continuing Operations 138 month | Net Cash Provided by (Used in) Financing Activities, Continuing Operations 141 month | Net Cash Provided by (Used in) Financing Activities, Continuing Operations 144 month | Net Cash Provided by (Used in) Financing Activities, Continuing Operations 147 month | Net Cash Provided by (Used in) Financing Activities, Continuing Operations 150 month | Net Cash Provided by (Used in) Financing Activities, Continuing Operations 153 month | Net Cash Provided by (Used in) Financing Activities, Continuing Operations 156 month | Net Cash Provided by (Used in) Financing Activities, Continuing Operations 159 month | Net Cash Provided by (Used in) Financing Activities, Continuing Operations 162 month |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2017-09-30 | $75.00K 10-Q · filed 2017-10-17 | $105.00K derived: sum of 2 quarters · filed 2017-10-17 | $105.00K 10-Q · filed 2017-10-17 | $105.00K derived: sum of 4 quarters · filed 2017-10-17 | ||||||||||||
| 2017-06-30 | $30.00K 10-Q · filed 2017-08-14 | $30.00K 10-Q · filed 2017-08-14 | $30.00K derived: sum of 3 quarters · filed 2017-08-14 | $30.00K derived: sum of 4 quarters · filed 2017-10-17 | ||||||||||||
| 2017-03-31 | $0.00 10-Q · filed 2017-05-15 | $0.00 derived: sum of 2 quarters · filed 2017-05-15 | $0.00 derived: sum of 3 quarters · filed 2017-10-17 | $0.00 derived: sum of 4 quarters · filed 2017-10-17 | ||||||||||||
| 2016-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-29 | $0.00 derived: sum of 2 quarters · filed 2017-10-17 | $0.00 derived: sum of 3 quarters · filed 2017-10-17 | $0.00 10-K · filed 2017-03-29 | ||||||||||||
| 2016-09-30 | $0.00 10-Q · filed 2017-10-17 | $0.00 derived: sum of 2 quarters · filed 2017-10-17 | $0.00 10-Q · filed 2017-10-17 | $111.00K derived: sum of 4 quarters · filed 2017-10-17 | ||||||||||||
| 2016-06-30 | $0.00 10-Q · filed 2017-08-14 | $0.00 10-Q · filed 2017-08-14 | $111.00K derived: sum of 3 quarters · filed 2017-08-14 | $111.00K derived: sum of 4 quarters · filed 2017-08-14 | ||||||||||||
| 2016-03-31 | $0.00 10-Q · filed 2017-05-15 | $111.00K derived: sum of 2 quarters · filed 2017-05-15 | $111.00K derived: sum of 3 quarters · filed 2017-05-15 | $123.00K derived: sum of 4 quarters · filed 2017-05-15 | ||||||||||||
| 2015-12-31 | $111.00K derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-29 | $111.00K derived: sum of 2 quarters · filed 2017-03-29 | $123.00K derived: sum of 3 quarters · filed 2017-03-29 | $14.87M 10-K · filed 2017-03-29 | ||||||||||||
| 2015-09-30 | $0.00 10-Q · filed 2016-11-14 | $12.00K derived: sum of 2 quarters · filed 2016-11-14 | $14.76M 10-Q · filed 2016-11-14 | $14.80M derived: sum of 4 quarters · filed 2016-11-14 | ||||||||||||
| 2015-06-30 | $12.00K 10-Q · filed 2016-08-11 | $14.76M 10-Q · filed 2016-08-11 | $14.80M derived: sum of 3 quarters · filed 2016-08-11 | $15.17M derived: sum of 4 quarters · filed 2016-08-11 | ||||||||||||
| 2015-03-31 | $14.74M 10-Q · filed 2016-05-10 | $14.79M derived: sum of 2 quarters · filed 2016-05-10 | $15.16M derived: sum of 3 quarters · filed 2016-05-10 | $24.43M derived: sum of 4 quarters · filed 2016-05-10 | ||||||||||||
| 2014-12-31 | $46.00K derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-09 | $412.00K derived: sum of 2 quarters · filed 2016-03-09 | $9.69M derived: sum of 3 quarters · filed 2016-03-09 | $9.69M 10-K · filed 2016-03-09 | ||||||||||||
| 2014-09-30 | $366.00K 10-Q · filed 2015-11-16 | $9.64M derived: sum of 2 quarters · filed 2015-11-16 | $9.64M 10-Q · filed 2015-11-16 | $9.64M derived: sum of 4 quarters · filed 2015-11-16 | ||||||||||||
| 2014-06-30 | $9.27M 10-Q · filed 2015-08-13 | $9.27M 10-Q · filed 2015-08-13 | $9.27M derived: sum of 3 quarters · filed 2015-08-13 | $12.60M derived: sum of 4 quarters · filed 2015-08-13 | ||||||||||||
| 2014-03-31 | $0.00 10-Q · filed 2014-05-13 | $1.00K derived: sum of 2 quarters · filed 2014-05-13 | $3.33M derived: sum of 3 quarters · filed 2014-05-13 | $3.33M derived: sum of 4 quarters · filed 2014-05-13 | $23.16M 10-Q · filed 2014-05-13 | |||||||||||
| 2013-12-31 | $1.00K derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-27 | $3.33M derived: sum of 2 quarters · filed 2014-03-27 | $3.33M derived: sum of 3 quarters · filed 2014-03-27 | $3.58M 10-K · filed 2014-03-27 | $23.16M 10-K · filed 2014-03-27 | |||||||||||
| 2013-09-30 | $3.33M 10-Q · filed 2013-11-14 | $3.33M derived: sum of 2 quarters · filed 2013-11-14 | $3.58M 10-Q · filed 2013-11-14 | $3.58M derived: sum of 4 quarters · filed 2014-05-13 | $23.16M 10-Q · filed 2013-11-14 | |||||||||||
| 2013-06-30 | $7.00K 10-Q · filed 2013-08-14 | $257.00K 10-Q · filed 2013-08-14 | $252.00K derived: sum of 3 quarters · filed 2014-05-13 | $5.28M derived: sum of 4 quarters · filed 2014-05-13 | $19.84M 10-Q · filed 2013-08-14 | |||||||||||
| 2013-03-31 | $250.00K 10-Q · filed 2014-05-13 | $245.00K derived: sum of 2 quarters · filed 2014-05-13 | $5.27M derived: sum of 3 quarters · filed 2014-05-13 | $5.40M derived: sum of 4 quarters · filed 2014-05-13 | $19.83M 10-Q · filed 2013-05-09 | |||||||||||
| 2012-12-31 | -$5.00K derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-27 | $5.02M derived: sum of 2 quarters · filed 2014-03-27 | $5.15M derived: sum of 3 quarters · filed 2014-03-27 | $5.17M 10-K · filed 2014-03-27 | $19.58M 10-K · filed 2013-03-14 | |||||||||||
| 2012-09-30 | $5.03M 10-Q · filed 2013-11-14 | $5.15M derived: sum of 2 quarters · filed 2013-11-14 | $5.17M 10-Q · filed 2013-11-14 | $5.20M derived: sum of 4 quarters · filed 2013-11-14 | $19.58M 10-Q · filed 2012-11-13 | |||||||||||
| 2012-06-30 | $126.00K 10-Q · filed 2013-08-14 | $146.00K 10-Q · filed 2013-08-14 | $168.00K derived: sum of 3 quarters · filed 2013-08-14 | $557.00K derived: sum of 4 quarters · filed 2013-08-14 | $14.56M 10-Q/A · filed 2012-08-29 | |||||||||||
| 2012-03-31 | $20.00K 10-Q · filed 2013-05-09 | $42.00K derived: sum of 2 quarters · filed 2013-05-09 | $431.00K derived: sum of 3 quarters · filed 2013-05-09 | $475.00K derived: sum of 4 quarters · filed 2013-05-09 | $14.43M 10-Q · filed 2012-05-11 | |||||||||||
| 2011-12-31 | $22.00K derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-14 | $411.00K derived: sum of 2 quarters · filed 2013-03-14 | $455.00K derived: sum of 3 quarters · filed 2013-03-14 | $4.12M 10-K · filed 2013-03-14 | $14.41M 10-K · filed 2012-03-15 | |||||||||||
| 2011-09-30 | $389.00K 10-Q · filed 2012-11-13 | $433.00K derived: sum of 2 quarters · filed 2012-11-13 | $4.09M 10-Q · filed 2012-11-13 | $3.98M derived: sum of 4 quarters · filed 2012-11-13 | $14.39M 10-Q · filed 2011-11-14 | |||||||||||
| 2011-06-30 | $44.00K derived: 10-Q/A 6 month − 10-Q 3 month · filed 2012-08-29 | $3.71M 10-Q/A · filed 2012-08-29 | $3.59M derived: sum of 3 quarters · filed 2012-08-29 | $4.02M derived: sum of 4 quarters · filed 2012-08-29 | $14.00M 10-Q/A · filed 2011-09-07 | |||||||||||
| 2011-03-31 | $3.66M 10-Q · filed 2012-05-11 | $3.55M derived: sum of 2 quarters · filed 2012-05-11 | $3.98M derived: sum of 3 quarters · filed 2012-05-11 | |||||||||||||
| 2010-12-31 | -$113.00K derived: 10-K 12 month − 10-Q 9 month · filed 2012-03-15 | $313.00K derived: sum of 2 quarters · filed 2012-03-15 | $2.16M 10-K · filed 2012-03-15 | |||||||||||||
| 2010-09-30 | $426.00K derived: 10-Q 9 month − 10-Q/A 6 month · filed 2011-11-14 | $2.27M 10-Q · filed 2011-11-14 | ||||||||||||||
| 2010-06-30 | $1.85M 10-Q/A · filed 2011-09-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| INTENSITY THERAPEUTICS, INC. (INTS) | United States | $0.013B | -1.08 |
| Pluri Inc. (PLUR) | $0.014B | ||
| IN8BIO, INC. (INAB) | United States | $0.012B | -0.76 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| Passage BIO, Inc. (PASG) | United States | $0.015B | -0.43 |
| DYADIC INTERNATIONAL INC (DYAI) | United States | $0.016B | |
| BioCardia, Inc. (BCDA) | United States | $0.016B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| Jasper Therapeutics, Inc. (JSPR) | United States | $0.020B | -0.37 |